DEER VII & CO LTD
Q1 2018 Form 13-F
CIK 0001540726
· Institutional investment manager
$26.8M Reported Value Total
Reported value
$26.8M
Quarter over quarter
+8.3%
Holdings
3
Top-10 concentration
100.0%
Filing Structure
Reports holdings for
- Deer VII & Co. L.P. (not a 13F filer in our records) · Q1 2017 – Q3 2021 · declared by one filing
- Deer VII & Co. L.P. (not a 13F filer in our records) · File #28-15361 · Q2 2013 – Q4 2016 · declared by one filing
Key People
Named on the latest Form 13-F filing — not necessarily an owner
Scott Ring
General Counsel
Filing Navigation
Coverage begins with the second quarter of 2013. Earlier quarters are not shown while their accuracy is being verified.
13F Metrics
Loading 13F Metrics
Q1 2018 13F record
Q1 2018 13F filing summary
| Period of report | March 31, 2018 |
|---|---|
| Filed | May 15, 2018 |
| Form | 13F-HR |
| Reported value | $26.8M |
| Positions | 3 |
| Change in reported value | +8.2% |
| New positions | 0 |
| Exited positions | 0 |
| Position turnover | 0.0% |
| Top-10 concentration | 100.0% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2021 13F
Filed Nov 15, 2021
|
1 | $317.0M |
|
Q2 2021 13F
Filed Aug 16, 2021
|
1 | $420.8M |
|
Q1 2021 13F
Filed May 14, 2021
|
2 | $381.2M |
|
Q4 2020 13F
Filed Feb 16, 2021
|
2 | $344.3M |
|
Q3 2020 13F
Filed Nov 16, 2020
|
2 | $432.4M |
|
Q2 2020 13F
Filed Aug 14, 2020
|
2 | $259.4M |
|
Q1 2020 13F
Filed May 15, 2020
|
3 | $101.2M |
|
Q4 2019 13F
Filed Feb 14, 2020
|
4 | $102.8M |
|
Q3 2019 13F
Filed Nov 14, 2019
|
5 | $86.6M |
|
Q2 2019 13F
Filed Aug 14, 2019
|
4 | $114.2M |
|
Q1 2019 13F
Filed May 15, 2019
|
4 | $31.8M |
|
Q4 2018 13F
Filed Feb 14, 2019
|
4 | $35.9M |
|
Q3 2018 13F
Filed Nov 14, 2018
|
4 | $66.7M |
|
Q2 2018 13F
Filed Aug 14, 2018
|
4 | $83.7M |
|
Q1 2018 13F
Filed May 15, 2018
|
3 | $26.8M |
|
Q4 2017 13F
Filed Feb 14, 2018
|
3 | $24.7M |
|
Q3 2017 13F
Filed Nov 14, 2017
|
2 | $6.2M |
|
Q2 2017 13F
Filed Aug 14, 2017
|
2 | $3.1M |
|
Q1 2017 13F
Filed May 15, 2017
|
2 | $3.0M |
|
Q4 2016 13F
Filed Feb 14, 2017
|
4 | $2.3M |
14 earlier quarters on file — choose one from the quarter menu above.
Top 3 holdings · Q1 2018
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | ALNAQ ALLENA PHARMACEUTICALS, INC. | $22.4M | 83.81% |
| 2 | VSTM VERASTEM INC | $3.5M | 13.24% |
| 3 | TARA PROTEON THERAPEUTICS INC | $788.0K | 2.94% |
Values as reported on the Q1 2018 Form 13F. Every position is in the holdings table below.